Mercedes, a retired teacher in her 50s, was filled with hope when her doctor prescribed her GLP-1 weight loss medications. After years of struggling with obesity, she thought these medications would finally help her. However, despite trying various drugs like Ozempic, Wegovy, and Mounjaro, she found no success in losing weight, which severely impacted her self-esteem.
The excitement surrounding GLP-1 medications is palpable due to their ability to promote weight loss and manage other health conditions. However, clinical trials reveal that a significant portion of users—between 9% and one-third—lose little to no weight. Researchers are trying to uncover why some individuals don’t respond effectively to these medications. Factors like age, sex, ancestry, and possibly hormonal influences can affect the results, but predicting who will respond positively remains elusive.
Others, like Yury and Lucille, share similar struggles, experiencing either minimal weight loss or no improvement at all despite maintaining healthy lifestyles while on medication. The emotional toll is profound, as many feel disappointed and ashamed when they see little benefit from treatments that others rave about.
Emerging research is exploring the role of genetics and hormonal influences on GLP-1 response. While promising new drugs and approaches are in development, those who do not respond to GLP-1 medications often need to consider other options, including weight-loss surgery.
Professors and medical experts emphasize that individual responses to these medications are not the patient’s fault, reflecting the complex nature of obesity treatment. Mercedes’s experience highlights the frustrating reality that, despite the hype, GLP-1 medications do not work for everyone, underscoring the need for ongoing research into more effective solutions.
